These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26433424)

  • 21. The effects of the FDA warning on the use of droperidol by u.s. Emergency physicians.
    Richards JR; Weiss SJ; Bretz SW; Schneir AB; Rinetti D; Derlet RW
    Cal J Emerg Med; 2003 Jan; 4(1):3-9. PubMed ID: 20852711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey.
    Friedman BW; West J; Vinson DR; Minen MT; Restivo A; Gallagher EJ
    Cephalalgia; 2015 Apr; 35(4):301-9. PubMed ID: 24948146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy.
    McAllister-Williams RH; Ferrier IN
    Br J Psychiatry; 2002 Jun; 180():485-9. PubMed ID: 12042225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular medication for treatment of agitation in the emergency department: A systematic review of controlled trials.
    Schneider A; Mullinax S; Hall N; Acheson A; Oliveto AH; Wilson MP
    Am J Emerg Med; 2021 Aug; 46():193-199. PubMed ID: 33071100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.
    Kim HM; Chiang C; Kales HC
    Psychiatr Serv; 2011 Oct; 62(10):1207-14. PubMed ID: 21969648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department.
    Rund DA; Ewing JD; Mitzel K; Votolato N
    J Emerg Med; 2006 Oct; 31(3):317-24. PubMed ID: 16982374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Resnick M; Burton BT
    J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
    Jain S; Greenbaum MA; Rosen C
    Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia.
    Habib AS; Gan TJ
    J Clin Anesth; 2008 Feb; 20(1):35-9. PubMed ID: 18346607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010.
    Gallini A; Gardette V; Oumouhou N; Andrieu S; Donohue JM
    Psychiatr Serv; 2015 Apr; 66(4):434-7. PubMed ID: 25588416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic drug use since the FDA black box warning: survey of nursing home policies.
    Lester P; Kohen I; Stefanacci RG; Feuerman M
    J Am Med Dir Assoc; 2011 Oct; 12(8):573-577. PubMed ID: 21450177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
    Martel M; Sterzinger A; Miner J; Clinton J; Biros M
    Acad Emerg Med; 2005 Dec; 12(12):1167-72. PubMed ID: 16282517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Droperidol for the treatment of acutely agitated patients: still an option].
    Budiharto L; De Fruyt J
    Tijdschr Psychiatr; 2013; 55(3):183-92. PubMed ID: 23512631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating primary headaches in the ED: can droperidol regain its role?
    Faine B; Hogrefe C; Van Heukelom J; Smelser J
    Am J Emerg Med; 2012 Sep; 30(7):1255-62. PubMed ID: 22030187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotic medications in the psychiatric emergency service.
    Currier GW
    J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription patterns of psychotropic medications for the treatment of psychotic disorders in the largest mental health institutions of Uganda.
    Rukat A; Musisi S; Ströhle A; Mundt AP
    J Clin Psychopharmacol; 2014 Oct; 34(5):571-6. PubMed ID: 24943390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M; King M; Schoenbaum M
    JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.